|Check Out DNA Fingerprint Plus $300
New Center is Hiring
The University of North Carolina at Chapel Hill dedicated its new Genome Sciences Building on University Day, Oct. 12, 2012, a major event in the increasingly interdisciplinary world of genome science. Located at the geographical center of campus, the Genome Sciences Building has an overarching goal: to foster collaborations at the intersection of different disciplines – and in every way, it is designed to do just that, according to the university.
“Proximity is really important in a busy world,” says Jeff Dangl, Howard Hughes Medical Institute investigator and John N. Couch Professor of Biology. “The explicit concept of this building is let’s hire new people at the interface of all of our traditional disciplines. Let’s give them a home – or at least a foothold – here in this building and see what comes of it in terms of generating new synergistic science.”
Symbolically, the building's footprint lies on the border between the College of Arts and Sciences and the five health affairs schools, where basic research meets clinical applications. Researchers from departments as diverse as biology, chemistry, computer science and statistics have opportunities to interact with each other in the building and are very closely located to colleagues in the schools of medicine, pharmacy, nursing, dentistry, public health, and information and library science.
DNA Consultants' founder and chief research officer, Donald Yates, has a Ph.D. from the University of North Carolina at Chapel Hill. We applaud the new center's interdisciplinary mission and bridging of sciences including the campus' traditional strengths in statistics, computer and library science.
In 2012, UNC rose to 9th in the nation for federal funding devoted to research and development. The current level of $546 million during fiscal 2010 is spread among all fields and puts the university fourth among public campuses in the country.
One of the projects supported by such research was the Cancer Genome Atlas program led by Carolina's Charles Perou, professor of molecular oncology. Perou's team published their work in the journal Nature and opened the way to personalized treatment of breast cancer, as widely reported in the media, including the front page of the New York Times.